Literature DB >> 23642723

Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Mazen M Dimachkie1, Richard J Barohn, Jonathan Katz.   

Abstract

Chronic acquired demyelinating neuropathies (CADP) constitute an important group of immune neuromuscular disorders affecting myelin. This article discusses CADP with emphasis on multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, distal acquired demyelinating symmetric neuropathy, and less common variants. Although each of these entities has distinctive laboratory and electrodiagnostic features that aid in their diagnosis, clinical characteristics are of paramount importance in diagnosing specific conditions and determining the most appropriate therapies. Knowledge regarding pathogenesis, diagnosis, and management of these disorders continues to expand, resulting in improved opportunities for identification and treatment.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23642723      PMCID: PMC4098937          DOI: 10.1016/j.ncl.2013.01.001

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  154 in total

1.  Pure motor chronic inflammatory demyelinating polyneuropathy.

Authors:  M Sabatelli; F Madia; T Mignogna; G Lippi; L Quaranta; P Tonali
Journal:  J Neurol       Date:  2001-09       Impact factor: 4.849

2.  A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM.

Authors:  X Mariette; J C Brouet; S Chevret; J M Leger; P Clavelou; J Pouget; J M Vallat; C Vial
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

Review 3.  Clinical spectrum of chronic acquired demyelinating polyneuropathies.

Authors:  D S Saperstein; J S Katz; A A Amato; R J Barohn
Journal:  Muscle Nerve       Date:  2001-03       Impact factor: 3.217

4.  Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis.

Authors:  N Mowzoon; A Sussman; W G Bradley
Journal:  J Neurol Sci       Date:  2001-04-01       Impact factor: 3.181

5.  Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies.

Authors:  E Nobile-Orazio; N Meucci; L Baldini; A Di Troia; G Scarlato
Journal:  Brain       Date:  2000-04       Impact factor: 13.501

6.  Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy?

Authors:  S J Oh; G C Claussen; D S Kim
Journal:  J Peripher Nerv Syst       Date:  1997       Impact factor: 3.494

7.  The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies.

Authors:  H J Willison; C P O'Leary; J Veitch; L D Blumhardt; M Busby; M Donaghy; P Fuhr; H Ford; A Hahn; S Renaud; H A Katifi; S Ponsford; M Reuber; A Steck; I Sutton; W Schady; P K Thomas; A J Thompson; J M Vallat; J Winer
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

8.  Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.

Authors:  V Chaudhry; D R Cornblath; J W Griffin; R O'Brien; D B Drachman
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

9.  Natural history of 46 patients with multifocal motor neuropathy with conduction block.

Authors:  B V Taylor; R A Wright; C M Harper; P J Dyck
Journal:  Muscle Nerve       Date:  2000-06       Impact factor: 3.217

10.  Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.

Authors:  W M Bosboom; L H van den Berg; H Franssen; P C Giesbergen; H Z Flach; A M van Putten; H Veldman; J H Wokke
Journal:  Brain       Date:  2001-12       Impact factor: 13.501

View more
  9 in total

Review 1.  The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.

Authors:  Brian C Callaghan; Raymond S Price; Kevin S Chen; Eva L Feldman
Journal:  JAMA Neurol       Date:  2015-12       Impact factor: 18.302

2.  Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.

Authors:  John W Rumsey; Case Lorance; Max Jackson; Trevor Sasserath; Christopher W McAleer; Christopher J Long; Arindom Goswami; Melissa A Russo; Shruti M Raja; Karissa L Gable; Doug Emmett; Lisa D Hobson-Webb; Manisha Chopra; James F Howard; Jeffrey T Guptill; Michael J Storek; Miguel Alonso-Alonso; Nazem Atassi; Sandip Panicker; Graham Parry; Timothy Hammond; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2022-04-05

3.  Pattern-recognition approach to neuropathy and neuronopathy.

Authors:  Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

4.  Multifocal acquired demyelinating sensory and motor neuropathy misdiagnosed as carpal tunnel syndrome: a case report.

Authors:  Soyoung Kwak; Mathieu Boudier-Revéret; Hee Kyung Cho; Min Cheol Chang
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

Review 5.  Neuromuscular issues in systemic disease.

Authors:  Wolfgang Grisold; Anna Grisold
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 6.030

Review 6.  Human immune globulin infusion in the management of multifocal motor neuropathy.

Authors:  Elizabeth Jovanovich; Chafic Karam
Journal:  Degener Neurol Neuromuscul Dis       Date:  2015-12-22

Review 7.  Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19.

Authors:  Dipak Kumar; Sadaf Jahan; Andleeb Khan; Arif Jamal Siddiqui; Neeru Singh Redhu; Johra Khan; Saeed Banwas; Bader Alshehri; Mohammed Alaidarous
Journal:  Mol Neurobiol       Date:  2021-03-14       Impact factor: 5.590

Review 8.  Expanding the Role of the Pharmacist: Immunoglobulin Therapy and Disease Management in Neuromuscular Disorders.

Authors:  Eric M Tichy; Barbara Prosser; Drew Doyle
Journal:  J Pharm Pract       Date:  2020-07-17

Review 9.  Evidence from Human and Animal Studies: Pathological Roles of CD8(+) T Cells in Autoimmune Peripheral Neuropathies.

Authors:  Mu Yang; Corentin Peyret; Xiang Qun Shi; Nicolas Siron; Jeong Ho Jang; Sonia Wu; Sylvie Fournier; Ji Zhang
Journal:  Front Immunol       Date:  2015-10-15       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.